The first rule are hospitals that participate in Medicare and Medicaid, which is almost every hospital, from performing these dangerous and harmful procedures. The second rule prohibits the federal Medicaid dollars from funding the sex rejecting procedures on minors. The FDA is issuing warning letters to 12 manufacturers of breast binders which are medical devices used for purposes such as assistance in recovery from cancer related mastectomies. The FDA is telling these companies that the illegal marketing of breast binders to children for the purpose of treating gender dysphoria commits significant regulatory violations and requires swift congressional or corrective action. (03:55–04:07)
CLAIM
Asserts that the FDA is warning manufacturers about the marketing of breast binders to children.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
